Follow the 코오롱티슈진 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 코오롱티슈진 has recorded 28 public disclosures. Market capitalisation: €1,099bn. The latest transaction was disclosed on 15 May 2026 (Purchase). Among the most active insiders: 코오롱. All data is accessible without an account.
23
Insider Decl.
n/a
Thresholds
€37m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
20Σ signal
Buys €37mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Kolon TissueGene is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of regenerative therapies and innovative pharmaceutical products.